NO140299C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-onerInfo
- Publication number
- NO140299C NO140299C NO4002/73A NO400273A NO140299C NO 140299 C NO140299 C NO 140299C NO 4002/73 A NO4002/73 A NO 4002/73A NO 400273 A NO400273 A NO 400273A NO 140299 C NO140299 C NO 140299C
- Authority
- NO
- Norway
- Prior art keywords
- oxsazolin
- oners
- aminoalkyl
- aryl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT3053672 | 1972-10-16 | ||
| IT2811573A IT1056733B (it) | 1973-08-22 | 1973-08-22 | 4 aril 5 aminoalohil 4 ossazolin 2 oni loro derivati e processi per la loro preparazione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO140299B NO140299B (no) | 1979-04-30 |
| NO140299C true NO140299C (no) | 1979-08-08 |
Family
ID=26328766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO4002/73A NO140299C (no) | 1972-10-16 | 1973-10-15 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3930008A (da) |
| JP (1) | JPS4993360A (da) |
| CA (1) | CA1016550A (da) |
| CH (1) | CH605859A5 (da) |
| DE (1) | DE2351948A1 (da) |
| DK (1) | DK135122B (da) |
| ES (1) | ES419632A1 (da) |
| FI (1) | FI57752C (da) |
| FR (1) | FR2202701B1 (da) |
| GB (1) | GB1429571A (da) |
| NL (1) | NL161154C (da) |
| NO (1) | NO140299C (da) |
| SE (1) | SE391717B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4123529A (en) * | 1976-04-23 | 1978-10-31 | Lilly Industries Limited | Phenylpiperazine derivatives |
| PT77428B (fr) * | 1982-10-05 | 1986-02-27 | Cortial | Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant |
| FR2546167B2 (fr) * | 1983-05-19 | 1985-07-12 | Cortial | Nouvelles amino-2 piperazino et piperidinomethyl-5 oxazolines-2, leur methode de preparation ainsi que leur application therapeutique |
| CN1008735B (zh) | 1984-11-02 | 1990-07-11 | 拜尔公司 | 以取代的氮杂茂基甲基-环丙基-甲醇衍生物为活性成分的组合物 |
| US4728661A (en) * | 1985-11-13 | 1988-03-01 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic phenyl oxazolones |
| US6159990A (en) * | 1997-06-18 | 2000-12-12 | Synaptic Pharmaceutical Corporation | Oxazolidinones as α1A receptor antagonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3576808A (en) * | 1967-09-15 | 1971-04-27 | Miles Lab | N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones |
| JPS4922770A (da) * | 1972-06-22 | 1974-02-28 |
-
1973
- 1973-10-03 US US403275A patent/US3930008A/en not_active Expired - Lifetime
- 1973-10-11 CH CH1449973A patent/CH605859A5/xx not_active IP Right Cessation
- 1973-10-12 GB GB4787573A patent/GB1429571A/en not_active Expired
- 1973-10-15 SE SE7313966A patent/SE391717B/xx unknown
- 1973-10-15 FI FI3183/73A patent/FI57752C/fi active
- 1973-10-15 NL NL7314147.A patent/NL161154C/xx not_active IP Right Cessation
- 1973-10-15 NO NO4002/73A patent/NO140299C/no unknown
- 1973-10-15 ES ES419632A patent/ES419632A1/es not_active Expired
- 1973-10-15 CA CA183,418A patent/CA1016550A/en not_active Expired
- 1973-10-16 DE DE19732351948 patent/DE2351948A1/de not_active Withdrawn
- 1973-10-16 FR FR7336838A patent/FR2202701B1/fr not_active Expired
- 1973-10-16 DK DK560273AA patent/DK135122B/da unknown
- 1973-10-16 JP JP48116238A patent/JPS4993360A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB1429571A (en) | 1976-03-24 |
| AU6121673A (en) | 1975-04-10 |
| DE2351948A1 (de) | 1974-04-25 |
| ES419632A1 (es) | 1976-06-16 |
| DK135122C (da) | 1977-08-08 |
| NO140299B (no) | 1979-04-30 |
| SE391717B (sv) | 1977-02-28 |
| NL161154B (nl) | 1979-08-15 |
| FI57752B (fi) | 1980-06-30 |
| NL161154C (nl) | 1980-01-15 |
| US3930008A (en) | 1975-12-30 |
| DK135122B (da) | 1977-03-07 |
| CH605859A5 (da) | 1978-10-13 |
| JPS4993360A (da) | 1974-09-05 |
| FI57752C (fi) | 1980-10-10 |
| CA1016550A (en) | 1977-08-30 |
| NL7314147A (da) | 1974-04-18 |
| FR2202701A1 (da) | 1974-05-10 |
| FR2202701B1 (da) | 1980-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO140059B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater | |
| NO137941C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin | |
| NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
| NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
| NO136837C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
| NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
| NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
| NO140057C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater | |
| NO137824C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkyltetrazoler | |
| NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
| NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
| NO140824C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener | |
| NO137151C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider | |
| NO138063C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
| NO138026C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
| NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner | |
| NO138025C (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
| NO138251C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer | |
| NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
| NO138285C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater |